Clinical Study

An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable

Posted Date: Jan 28, 2020

  • Investigator: Caleb Adler
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Drug

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia (The RISE Study – The RIsperidone Subcutaneous Extended-release Study)

Criteria:

13 Through 65 Years, Diagnosis Of Schizophrenia

Keywords:

Adult, Adolescent, Schizophrenia

For More Information:

Karen Tugrul, Bsn, Rn
513.558.6831
karen.tugrul@uc.edu